Loading company details...
Beta
Latest Form 4 (Jun 24, 2026): Robert J. Hombach (Director): Purchase of 13,000 shares, $235.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 24, 2026 | Robert J. Hombach | Purchase | 13,000 | $235.8K |
| May 6, 2026 | PureTech Health plc | Conversion | 12,736,014 | n/a |
| May 4, 2026 | Daphne Zohar, Chief Executive Officer | Grant/Award | 271,813 | n/a |
| May 4, 2026 | James Healy | Conversion | 1,927,159 | n/a |
| May 4, 2026 | Lauren White, Chief Financial Officer | Conversion | 6,702 | n/a |
| May 4, 2026 | David E. Wheadon | Grant/Award | 12,258 | n/a |
| May 4, 2026 | Sandra E. Peterson | Grant/Award | 12,258 | n/a |
| May 4, 2026 | Lana Gladstein, General Counsel | Conversion | 33,515 | n/a |
| May 4, 2026 | Michael Cunyuan Chen, Chief Scientific Officer | Conversion | 3,351 | n/a |
| May 4, 2026 | Denice Torres | Conversion | 13,406 | n/a |